CLOSE

Benchmark Investments

Nippon India Nifty Pharma ETF

very highequityindex
26.29 -0.05(-0.19%) NAV as on 21 Oct 2026
-5.4 % 1 M
14.34 % 1 Y
19.61 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

0.23

As on 30 Sep, 2026
Age :

5 yrs 3 m

Since 06 07 ,2021
Exit Load :

%

AUM :

1,736.44 Crs

Portfolio Price To Book Value :

8.07

Investing Style :

Large Growth

Min. Investment :

SIP NA & Lumpsum 1000

Category :

etfs

Fund Manager :

Jitendra Tolani

Launch Date :

06-Jul-21

Scheme Benchmark :

NA

FUND OBJECTIVE

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Sep 30 ,2026
Others 0.04 %
Equity 99.96 %

TOP HOLDINGS

Sun Pharmaceutical Industries...19.50 %
Divi's Laboratories Ltd.11.97 %
Laurus Labs Ltd.7.82 %
Cipla Ltd.7.68 %
Dr. Reddy's Laboratories Ltd.7.62 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs99.96
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)13.6512.1619.3221.5822.81
Net Assets(Rs Crores) (as on 31-Mar-2026) 87.63 197.85 643.07 856.43 1247.90
Scheme Returns(%)(Absolute)-5.25-10.9258.2110.487.56
B'mark Returns(%)(Absolute)NANANANANA
Category Rank109/111150/16029/20139/23866/323

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2026-202713.974.57NANA
2025-20264.34-2.375.88-2.00
2024-20253.8418.320.53-9.56
2023-202414.5312.509.1113.01
2022-2023-10.467.10-2.90-4.37

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Nifty Pharma ETFVery HighEquity26.29-0.05(-0.19%)NAV As on 22 Oct, 202606-Jul-2021Inception Date1,736.44AUM In Cr.14.34%1Y19.61%3Y13.08%5Y12.02%Since Inception
Nippon India ETF Nifty 50 BeESVery HighEquity260.24-0.89(-0.34%)NAV As on 22 Oct, 202628-Dec-2001Inception Date65,178.85AUM In Cr.-10.80%1Y6.47%3Y5.84%5Y14.53%Since Inception
Tata Nifty 50 ETFVery HighEquity248.73-0.85(-0.34%)NAV As on 22 Oct, 202601-Jan-2019Inception Date673.65AUM In Cr.-10.82%1Y6.42%3Y5.81%5Y11.13%Since Inception
Bandhan Nifty 50 ETFVery HighEquity252.43-0.86(-0.34%)NAV As on 22 Oct, 202607-Oct-2016Inception Date21.10AUM In Cr.-10.84%1Y6.41%3Y5.80%5Y11.19%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd